Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma. 2016

Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.

The prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma (GC) has been widely reported and is still under debate. Here, we evaluated the prognostic significance of preoperative serum CA125, CA19-9 and CEA in patients with GC. 1692 patients with GC who underwent gastrectomy were divided into the training (from January 2005 to December 2011, n = 1024) and the validation (from January 2012 to December 2013, n = 668) cohorts. Positive groups of CA125 (> 13.72 U/ml), CA19-9 (> 23.36 U/ml) and CEA (> 4.28 ng/ml) were significantly associated with more advanced clinicopathological traits and worse outcomes than that of negative groups (all P < 0.01). In Cox regression analysis, tumor size (P < 0.001, P = 0.005), pTNM stage (P < 0.001, P < 0.001) and CA125 (P = 0.026, P = 0.005) were independent prognostic factors both in two cohorts. Nomograms of these two cohorts based on the number of positive serum tumor markers (NPTM) were more accurate in prognostic prediction than TNM stage alone. Our findings suggested that elevated preoperative serum CA125, CA19-9 and CEA were associated with more advanced clinicopathological traits and less favorable outcomes. In addition, CA125 as an independent prognostic factor should be further investigated. Nomogram based on NPTM could accurately predict the prognosis of GC patients.

UI MeSH Term Description Entries
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
June 2004, Cancer research and treatment,
Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
January 2019, Disease markers,
Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
November 2017, BMC cancer,
Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
April 2020, Clinical laboratory,
Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
January 1996, The American journal of gastroenterology,
Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
March 1996, Minerva chirurgica,
Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
July 1999, Oncology,
Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
January 2021, Frontiers in oncology,
Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
September 2023, medRxiv : the preprint server for health sciences,
Wei Wang, and Xiao-Long Chen, and Shen-Yu Zhao, and Yu-Hui Xu, and Wei-Han Zhang, and Kai Liu, and Xin-Zu Chen, and Kun Yang, and Bo Zhang, and Zhi-Xin Chen, and Jia-Ping Chen, and Zong-Guang Zhou, and Jian-Kun Hu
June 2022, Anticancer research,
Copied contents to your clipboard!